This inventor holds 10 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Hyglos Invest Gmbh, Profos Ag, Biomerieux Sa. Active years: 2009-2016.
Location History:
- Schmidmühlen, DE (2009 - 2011)
- Schmidmühlem, DE (2013)
- Schmidmuhlen, DE (2012 - 2016)
Company Filing History:
8 out of 19 
2 out of 4 
1 out of 82 Years Active: 2009-2016
Title: The Innovative Mind of Roman Meyer
Introduction
Roman Meyer is an accomplished inventor from Schmidmuhlen, Germany. With a remarkable portfolio of ten patents, Meyer has made significant contributions to the field of biotechnology. His innovative work primarily focuses on bacteriophage tail proteins and their applications in purifying bacterial cells and components.
Latest Patents
Roman Meyer's recent patents highlight his commitment to advancing scientific knowledge. One notable patent is related to "Nucleic acids encoding bacteriophage tail proteins." This invention involves bacteriophage tail proteins and their derivatives which can effectively bind endotoxins without the need for bivalent positive ions like Calcium or Magnesium. Additionally, this patent presents methods for depleting endotoxins from various solutions and samples using these unique bacteriophage tail proteins, along with a detection method specifically designed for endotoxins.
Another significant patent pertains to "Methods for purification of bacterial cells and cell components." This invention describes a selective method for purifying bacterial cells and their components using a solid support, enhancing the efficiency and effectiveness of purification processes in biological research.
Career Highlights
Throughout his career, Roman Meyer has been affiliated with several notable companies, including Hyglos Invest GmbH and Profos AG. His work at these companies has facilitated advancements in the biotechnology industry, particularly in the realms of microbial research and purification techniques.
Collaborations
Roman Meyer has collaborated with skilled professionals in his field, including colleagues such as Stefan Miller and Holger Grallert. Together, they have worked on various projects that have pushed the boundaries of innovation, contributing to advancements in their respective areas of expertise.
Conclusion
As an inventor, Roman Meyer continues to shape the future of biotechnology through his innovative patents and collaborations. His work, particularly in the field of bacteriophage tail proteins and purification methods, underscores the importance of innovation in addressing complex scientific challenges. With a strong foundation and a drive for discovery, Roman Meyer exemplifies the spirit of modern inventors.